Oxford Immunotec appoints Frank Vandeputte
pharmafile | February 4, 2010 | Appointment | Sales and Marketing | Oxford Immunotec, appointment, medical devices, sales and marketing
Medical diagnostics company Oxford Immunotec has appointed Frank Vandeputte vice president, sales and marketing.
He was formerly VP, Europe for medical technology company CryoCath Technologies, where he was responsible for developing and implementing strategic and operational business plans.
He also led the European team though the company’s acquisition by Medtronic in November 2008.
With over 20 years experience in the medical device industry, Frank has held senior management positions with leading companies, including Baxter International, Becton Dickinson and Guidant Corporation.
The company has also added Dr Peter Klemm, president and chief executive of Predictive Biosciences, as a non-executive director.
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

FDA approves Abbott’s Assert-IQ insertable cardiac monitor
Abbott has announced that the US Food and Drug Administration (FDA) has granted its clearance …

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …






